Celebrating 25 years Est 1999-2024
*Across 3 years $3395.52 only $1358.21
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral...
Virax Biolabs to Participate at ESCMID Global 2024 PR Newswire LONDON, April 16, 2024 LONDON, April 16, 2024...
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency PR...
Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.